Skip to main content

TC Group Cayman Investment Holdings, L.P.'s Form 4 filing

Ortho Clinical Diagnostics Holdings plc (OCDX) · filed Sep 16, 2021

Accession no.
0000899243-21-036278
Filed
Sep 16, 2021, 4:30 PM ET
Trade date
Sep 14, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction. Open-market sales total $425.0M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
TC Group Cayman Investment Holdings, L.P.CIK 000147544410% Owner
Carlyle Group Inc.CIK 000152716610% Owner
Carlyle Holdings II GP L.L.C.CIK 000154862910% Owner
Carlyle Holdings II L.L.C.CIK 000154863010% Owner
TC Group Cayman Investment Holdings Sub L.P.CIK 000154863610% Owner
CG Subsidiary Holdings L.L.C.CIK 000179057710% Owner
TC Group VI Cayman, L.L.C.CIK 000183877410% Owner
Carlyle Partners VI Cayman Holdings, L.P.CIK 000183877610% Owner
TC Group VI Cayman, L.P.CIK 000183878110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 14, 2021Ordinary SharesSSaleDisposed−25,300,000$16.80−$425,040,000118,106,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)